Skip to content Skip to footer
Adalimumab-Atto: Benefits, Reviews, Info, Side Effects!
Rx Details
Adalimumab-Atto
Adalimumab, Humira, Amjevita, Cyltezo, Hadlima
Adalimumab
Prescription
Biologic
Drugs
Prescription Only
treats rheumatoid arthritis, reduces inflammation, improves joint function, treats psoriatic arthritis, treats ankylosing spondylitis, treats Crohn’s disease, treats ulcerative colitis, treats plaque psoriasis, treats hidradenitis suppurativa, treats uveitis
Abdominal Pain, Allergic Reactions, Back Pain, Dizziness, Fatigue, Headache, Hypertension, Increased Liver Enzymes, Increased Risk Of Infections, Injection Site Reactions, Nausea, Rash, Sinusitis, Upper Respiratory Infections, Urinary Tract Infections
Adalimumab-atto is a biosimilar to adalimumab, which is commonly used to treat various inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis, among others. The dosage of adalimumab-atto can vary depending on the specific condition being treated, the severity of the condition, and the patient’s response to the medication. For many conditions, the typical starting dosage of adalimumab (and its biosimilars like adalimumab-atto) is often 40 mg administered via subcutaneous injection every other week. However, some conditions may require an initial loading dose or adjustments based on the patient’s needs. It’s important to note that the exact dosage and administration schedule should be determined by a healthcare professional based on individual patient factors. Always consult with a healthcare provider for personalized medical advice and before starting any new medication.
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis
Adalimumab-Atto has a favorable safety profile.
No Interactions Reported
$1,000 – $2,000
$1,500

A Synopsis of

Adalimumab-Atto

Adalimumab-Atto is a medication that belongs to a class of drugs known as tumor necrosis factor (TNF) inhibitors. It is commonly used to treat a variety of inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis.

Adalimumab-Atto works by targeting and blocking TNF, a protein in the body that plays a key role in the inflammatory response. By inhibiting TNF, this medication helps to reduce inflammation and alleviate symptoms such as joint pain, stiffness, and swelling.

It is important to follow your healthcare provider’s instructions when taking Adalimumab-Atto. This medication is typically administered as an injection under the skin, and the dosing schedule may vary depending on the condition being treated. It is important to keep up with your scheduled injections to ensure the medication remains effective.

As with any medication, Adalimumab-Atto may cause side effects in some individuals. Common side effects may include injection site reactions, headache, and upper respiratory infections. It is important to report any unusual or severe side effects to your healthcare provider.

Before starting Adalimumab-Atto, be sure to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. This will help ensure that Adalimumab-Atto is safe and appropriate for you.

Overall, Adalimumab-Atto can be an effective treatment option for individuals with inflammatory conditions. By working to reduce inflammation and alleviate symptoms, this medication can help improve quality of life for those living with these chronic conditions.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN